Related Experiment Video
Updated: Aug 26, 2025

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Clinical characteristics and genotype analysis of five infants with cblX type of methylmalonic acidemia
Fei Wang1, Lili Liang2, Shiying Ling2
11. Department of Endocrinology, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China.
Insights
Cobalamin (cbl) X type methylmalonic acidemia (MMA) presents with severe neurological symptoms like epilepsy and developmental delay. Diagnosis requires combining clinical findings with genetic testing due to variable biochemical phenotypes.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Methylmalonic acidemia (MMA) comprises a group of inherited metabolic disorders.
- Cobalamin (cbl) X type MMA is a rare subtype linked to the HCFC1 gene.
Purpose of the Study:
- To investigate the clinical and genetic characteristics of infants diagnosed with cobalamin (cbl) X type methylmalonic acidemia (MMA).
Main Methods:
- Clinical data from 5 infants with cblX MMA were collected.
- Biochemical analyses included blood acylcarnitines and urinary organic acids.
- Whole exon gene sequencing and bioinformatics analysis identified pathogenic mutations in the HCFC1 gene.
Main Results:
- Four males and one female infant were diagnosed with cblX MMA, with onset between 0-6 months.
- Clinical features included intractable epilepsy and mental/motor retardation.
- Genetic analysis revealed known and novel mutations in the HCFC1 gene, with varying clinical and biochemical presentations.
Conclusions:
- CblX MMA manifests with severe neurological symptoms and metabolic abnormalities, primarily elevated homocysteine.
- Clinical and biochemical phenotypes can be discordant.
- Genetic testing is crucial for accurate diagnosis of cblX MMA.
Objective:
To investigate the clinical and genetic characteristics of infants with cobalamin (cbl) X type of methylmalonic acidemia (MMA).
Methods:
The clinical data of 5 infants with cblX type of MMA diagnosed in Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and Shanghai Children's Hospital from the year 2016 to 2020 were collected. The levels of blood acylcarnitines were detected by tandem mass spectrometry, the levels of urinary organic acids were detected by gas-chromatography mass spectrometry, the pathogenic genes were detected by whole exon gene sequencing, and the effect of new pathogenic mutations on three-dimensional protein structure was predicted by bioinformatics analysis.
Results:
Five infants with cblX type were diagnosed, including 4 males and 1 female, and the onset age was 0-6 months. The main clinical manifestations of 4 males were intractable epilepsy, mental and motor retardation, metabolic abnormalities presented mild increase of blood homocysteine level. Among them, 3 cases were accompanied by slight increase of urinary methylmalonic acid, and 1 case was accompanied by increase of blood propionylcarnitine (C3) and C3/acetylcarnitine (C2). Gene detection found that 2 cases carried a same hemizygous mutation c.344C>T (p.A115V) of HCFC1 gene, which was the most reported mutation, and the other 2 cases carried novel pathogenic mutations, c.92G>A (p.R31Q) and c.166G>C (p.V56L). These 3 gene mutations located in the Kelch domain of HCFC1 protein. One female infant carried a benign mutation of c.3731G>T (p.R1244L). Her clinical symptoms were mild, and only the urinary methylmalonic acid was slightly increased.
Conclusions:
The clinical manifestations of children with cblX type of MMA are intractable epilepsy, mental and motor retardation, and other serious neurological symptoms. Their metabolic abnormalities present the increase of blood homocysteine with methylmalonic acid (urinary methylmalonic acid or/and blood C3, C3/C2). The clinical and biochemical phenotypes are separated, so the diagnosis should be in combination with the results of gene testing.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
Inborn Errors of Metabolism
Pedigree Analysis
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Animal Mitochondrial Genetics
Lysosomal Hydrolases